Publikationen, an denen er mitarbeitet Borja Quiroga Gili (18)

2024

  1. Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study

    American Journal of Kidney Diseases

2017

  1. Adding access blood flow surveillance reduces thrombosis and improves arteriovenous fistula patency: A randomized controlled trial

    Journal of Vascular Access, Vol. 18, Núm. 4, pp. 352-358

  2. Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients

    American Journal of Nephrology, Vol. 45, Núm. 2, pp. 107-114

2016

  1. Creatine-kinase and dialysis patients, a helpful tool for stratifying cardiovascular risk?

    Nefrologia, Vol. 36, Núm. 1, pp. 51-56

  2. Hipertensión pulmonar en pacientes en hemodiálisis: prevalencia y factores asociados

    Medicina Clinica, Vol. 146, Núm. 4, pp. 143-147

  3. Protein-bound toxins: added value in their removal with high convective volumes

    Nefrologia, Vol. 36, Núm. 6, pp. 637-642

  4. Pulmonary hypertension is an independent predictor of cardiovascular events and mortality in haemodialysis patients

    Nephrology, Vol. 21, Núm. 4, pp. 321-326

  5. The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: A randomized clinical trial

    Journal of Vascular Access, Vol. 17, Núm. 1, pp. 13-19

2015

  1. Albumin Leakage in Online Hemodiafiltration, More Convective Transport, More Losses?

    Therapeutic Apheresis and Dialysis, Vol. 19, Núm. 3, pp. 267-271

  2. Body Composition Affects Urea Distribution Volume Estimated by Watson's Formula

    Journal of Renal Nutrition, Vol. 25, Núm. 5, pp. 420-425

  3. Crescentic glomerulonephritis: Data from the Spanish Glomerulonephritis Registry

    Internal Medicine Journal, Vol. 45, Núm. 5, pp. 557-562

2014

  1. Body composition affects the response to erythropoiesis-stimulating agents in patients with chronic kidney disease in dialysis

    Renal Failure, Vol. 36, Núm. 7, pp. 1073-1077

  2. Dose equivalence between continuous erythropoietin receptor activator (CERA), darbepoetin and epoetin in patients with advanced chronic kidney disease

    Hippokratia, Vol. 18, Núm. 4, pp. 315-318

  3. Estudio de sobrehidratación en los pacientes en diálisis y su relación con la inflamación

    Nefrologia, Vol. 34, Núm. 5, pp. 579-583

  4. Evaluation of methods based on creatinine and cystatin C to estimate glomerular filtration rate in chronic kidney disease

    International Urology and Nephrology, Vol. 46, Núm. 6, pp. 1161-1167

  5. Procalcitonin as an early predictor of acute infection in hemodialysis patients

    Nefrologia, Vol. 34, Núm. 3, pp. 341-346

2013

  1. Detection of patients at high risk for non-occlusive mesenteric ischemia in hemodialysis

    Journal of Surgical Research, Vol. 180, Núm. 1, pp. 51-55

  2. Diastolic dysfunction and high levels of new cardiac biomarkers as risk factors for cardiovascular events and mortality in hemodialysis patients

    Blood Purification, Vol. 36, Núm. 2, pp. 98-106